Glycogen synthase kinase-3β: Homologous regulation of cell surface insulin receptor level via controlling insulin receptor mRNA stability in adrenal chromaffin cells

Journal of Neurochemistry

Volumn 103, Issue 5, 2007, Pages 1883-1896

  Yokoo, Hiroki ^a   Nemoto, Takayuki ^a   Yanagita, Toshihiko ^a   Satoh, Shinya ^a   Yoshikawa, Norie ^a   Maruta, Toyoaki ^a   Wada, Akihiko ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adrenal chromaffin cells; Glycogen synthase kinase 3; Insulin receptors; Lithium; mRNA stability; Up and down regulation

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; BETA CATENIN; BREFELDIN A; CALPASTATIN; DACTINOMYCIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; INSULIN RECEPTOR; IODINE 125; LACTACYSTIN; LEUPEPTIN; LITHIUM CHLORIDE; MESSENGER RNA; SERINE; TYROSINE; VALPROIC ACID;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; CELL SURFACE; CHROMAFFIN CELL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; EMBRYO; ENDOCYTOSIS; ENZYME INHIBITION; GENETIC STABILITY; GENETIC TRANSCRIPTION; IC 50; INSULIN BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

ADRENAL GLANDS; ANALYSIS OF VARIANCE; ANIMALS; BETA CATENIN; CATTLE; CELLS, CULTURED; CHROMAFFIN CELLS; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; INSULIN; PHOSPHORYLATION; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTOR, INSULIN; RNA STABILITY; TYROSINE;

BOVINAE;

EID: 36248973165     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04929.x     Document Type: Article

References (49)

1. Adityanjee, Munshi K. R. Thampy A. (2005) The syndrome of irreversible lithium-effectuated neurotoxicity. Clin. Neuropharmacol. 28, 38 49.
2. Arao Y., Kikuchi A., Ikeda K., Nomoto S., Horiguchi H. Kayama F. (2002) A + U-rich-element RNA-binding factor 1/heterogeneous nuclear ribonucleoprotein D gene expression is regulated by oestrogen in the rat uterus. Biochem. J. 361, 125 132.
3. Barbieri M., Bonafè M., Franceschi C. Paolisso G. (2003) Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am. J. Physiol. Endocrinol. Metab. 285, E1064 E1071.
4. Brussee V., Cunningham F. A. Zochodne D. W. (2004) Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 53, 1824 1830.
5. Carro E. Torres-Aleman I. (2004) The role of insulin and insulin-like growth factor 1 in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur. J. Pharmacol. 490, 127 133.
6. +-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition. J. Diabetes Complicat. 10, 192 200.
7. Coghlan M. P., Culbert A. A., Cross D. A. E. et al. (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7, 793 803.
8. Cross D. A. E., Culbert A. A., Chalmers K. A., Facci L., Skaper S. D. Reith A. D. (2001) Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurons from death. J. Neurochem. 77, 94 102.
9. De Sarno P., Li X. Jope R. S. (2002) Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium. Neuropharmacology 43, 1158 1164.
10. Dikic I., Schlessinger J. Lax I. (1994) PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr. Biol. 4, 702 708.
11. Doble B. W. Woodgett J. R. (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175 1186.
12. Eldar-Finkelman H. Krebs E. G. (1997) Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc. Natl Acad. Sci. USA 94, 9660 9664.
13. Gould T. D., Chen G. Manji H. K. (2004) In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29, 32 38.
14. Gual P., Le Marchand-Brustel Y. Tanti J.-F. (2005) Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87, 99 109.
15. Guhaniyogi J. Brewer G. (2001) Regulation of mRNA stability in mammalian cells. Gene 265, 11 23.
16. Hoeflich K. P., Luo J., Rubie E. A., Tsao M.-S., Jin O. Woodgett J. R. (2000) Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406, 86 90.
17. Jiang H., Guo W., Liang X. Rao Y. (2005) Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3β and its upstream regulators. Cell 120, 123 135.
18. Jope R. S. (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24, 441 443.
19. Klein P. S. Melton D. A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA 93, 8455 8459.
20. Lee Y.-I., Seo M., Kim Y., Kim S.-Y., Kang U. G., Kim Y.-S. Juhnn Y.-S. (2005) Membrane depolarization induces the undulating phosphorylation/ dephosphorylation of glycogen synthase kinase 3β, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 280, 22044 22052.
21. Más A., Campión J., Aller P. Calle C. (1998) Epinephrine-induced reduction in insulin receptor mRNA level and stability in U-937 human promonocytic cells. Horm. Metab. Res. 30, 118 122.
22. Meijer L., Flajolet M. Greengard P. (2004) Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol. Sci. 25, 471 480.
23. Moroo I., Yamada T., Makino H., Tooyama I., McGeer P. L., McGeer E. G. Hirayama K. (1994) Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease. Acta Neuropathol. 87, 343 348.
24. Nemoto T., Yokoo H., Satoh S., Yanagita T., Sugano T., Yoshikawa N., Maruta T., Kobayashi H. Wada A. (2006) Constitutive activity of glycogen synthase kinase-3β: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells. Brain Res. 1110, 1 12.
25. Nemoto T., Yokoo H., Satoh S., Yanagita T., Yoshikawa N., Maruta T., Kobayashi H. Wada A. (2007) Glycogen synthase kinase-3β: regulation of insulin signaling molecules in adrenal chromaffin cells. J. Pharmacol. Sci. 103 (Suppl. I 90P.
26. Roh M.-S., Kang U. G., Shin S. Y., Lee Y. H., Jung H. Y., Juhnn Y.-S. Kim Y. S. (2003) Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3β after electroconvulsive shock in the rat brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 1 5.
27. Saitoh T., Yanagita T., Shiraishi S., Yokoo H., Kobayashi H., Minami S., Onitsuka T. Wada A. (2002) Down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation by inhibitor of 90-kDa heat-shock protein family: endoplasmic reticulum retention of monomeric insulin receptor precursor with calnexin in adrenal chromaffin cells. Mol. Pharmacol. 62, 847 855.
28. Sheflin L. G. Spaulding S. W. (2000) Testosterone and dihydrotestosterone regulate AUF1 isoforms in a tissue-specific fashion in the mouse. Am. J. Physiol. Endocrinol. Metab. 278, E50 E57.
29. Shiraishi S., Yokoo H., Kobayashi H., Yanagita T., Uezono Y., Minami S., Takasaki M. Wada A. (2000) Post-translational reduction of cell surface expression of insulin receptors by cyclosporin A, FK506 and rapamycin in bovine adrenal chromaffin cells. Neurosci. Lett. 293, 211 215.
30. 2+-ATPase inhibitor in adrenal chromaffin cells. Brain Res. 898, 152 157.
31. Song J., Wu L., Chen Z., Kohanski R. A. Pick L. (2003) Axons guided by insulin receptor in Drosophila visual system. Science 300, 502 505.
32. Sugano T., Yanagita T., Yokoo H., Satoh S., Kobayashi H. Wada A. (2006) Enhancement of insulin-induced PI3K/Akt/GSK-3β and ERK signaling by neuronal nicotinic receptor/PKC-α/ERK pathway: up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cells. J. Neurochem. 98, 20 33.
33. Takada Y., Fang X., Jamaluddin M. S., Boyd D. D. Aggarwal B. B. (2004) Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 279, 39541 39554.
34. Takahashi M., Yamada T., Tooyama I., Moroo I., Kimura H., Yamamoto T. Okada H. (1996) Insulin receptor mRNA in the substantia nigra in Parkinson's disease. Neurosci. Lett. 204, 201 204.
35. Thiel A., Heinonen M., Rintahaka J., Hallikainen T., Hemmes A., Dixon D. A., Haglund C. Ristimäki A. (2006) Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3β in gastric cancer cells. J. Biol. Chem. 281, 4564 4569.
36. Tolnay M., Juang Y.-T. Tsokos G. C. (2002) Protein kinase A enhances, whereas glycogen synthase kinase-3β inhibits, the activity of the exon 2-encoded transactivator domain of heterogeneous nuclear ribonucleoprotein D in a hierarchical fashion. Biochem. J. 363, 127 136.
37. Wada A. (2006) Roles of voltage-dependent sodium channels in neuronal development, pain, and neurodegeneration. J. Pharmacol. Sci. 102, 253 268.
38. Wada A., Yokoo H., Yanagita T. Kobayashi H. (2005a) New twist on neuronal insulin receptor signaling in health, disease, and therapeutics. J. Pharmacol. Sci. 99, 128 143.
39. Wada A., Yokoo H., Yanagita T. Kobayashi H. (2005b) Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J. Pharmacol. Sci. 99, 307 321.
40. Wilson G. M., Lu J., Sutphen K., Sun Y., Huynh Y. Brewer G. (2003a) Regulation of A + U-rich element-directed mRNA turnover involving reversible phosphorylation of AUF1. J. Biol. Chem. 278, 33029 33038.
41. AUF1 regulates binding to A + U-rich mRNA-destabilizing elements and protein-induced changes in ribonucleoprotein structure. J. Biol. Chem. 278, 33039 33048.
42. Yamamoto R., Yanagita T., Kobayashi H., Yuhi T., Yokoo H. Wada A. (1996) Up-regulation of functional voltage-dependent sodium channels by insulin in cultured bovine adrenal chromaffin cells. J. Neurochem. 67, 1401 1408.
43. Yamamoto R., Yanagita T., Kobayashi H., Yokoo H. Wada A. (1997) Up-regulation of sodium channel subunit mRNAs and their cell surface expression by antiepileptic valproic acid: activation of calcium channel and catecholamine secretion in adrenal chromaffin cells. J. Neurochem. 68, 1655 1662.
44. Yamamoto R., Kobayashi H., Yanagita T., Yokoo H., Kurose T., Shiraishi S., Minami S., Matsukura S. Wada A. (2000) Up-regulation of cell surface insulin receptor by protein kinase C-α in adrenal chromaffin cells: involvement of transcriptional and translational events. J. Neurochem. 75, 672 682.
45. Yan D., Guo L. Wang Y. (2006) Requirement of dendritic Akt degradation by the ubiquitin-proteasome system for neuronal polarity. J. Cell Biol. 174, 415 424.
46. + channel expression. J. Pharmacol. Sci. 103 (Suppl. I 101P.
47. Yokoo H., Saitoh T., Shiraishi S., Yanagita T., Sugano T., Minami S., Kobayashi H. Wada A. (2003) Distinct effects of ketone bodies on down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation in adrenal chromaffin cells. J. Pharmacol. Exp. Ther. 304, 994 1002.
48. Zhao W.-Q., Chen H., Quon M. J. Alkon D. L. (2004) Insulin and insulin receptor in experimental models of learning and memory. Eur. J. Pharmacol. 490, 71 81.
49. Zick Y. (2001) Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol. 11, 437 441.